Menu Search
Equities

OCI NV

OCI:AEX

OCI NV

Actions
Basic MaterialsChemicals
  • Price (EUR)26.70
  • Today's Change0.37 / 1.41%
  • Shares traded378.57k
  • 1 Year change+4.99%
  • Beta0.7567
Data delayed at least 15 minutes, as of Sep 19 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 16-Sep-24
Select bar for recommendation details.
Recommendations16-Sep-24
Buy3
Outperform6
Hold2
Sell0
Strong Sell0

Share price forecast in USD

The 10 analysts offering 12 month price targets for Oci NV have a median target of 32.93, with a high estimate of 34.87 and a low estimate of 28.89. The median estimate represents a 23.32% increase from the last price of 26.70.
High30.6%34.87
Med23.3%32.93
Low8.2%28.89

Dividends

Historical dividend information is not available for OCI NV.
Div growth (TTM)-100.00%
More ▼

Earnings history & estimates in USD

On Aug 02, 2024, Oci NV reported 2nd quarter 2024 earnings of 0.02 per share. This result was in line with the consensus of the 2 analysts following the company and outperformed last year's 2nd quarter results by 0.051.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate-464.84%
Oci NV reported annual 2023 losses of -0.773 per share on Feb 13, 2024.
Average growth rate+40.58%
More ▼

Revenue history & estimates in USD

OCI N.V. had 2nd quarter 2024 revenues of 1.21bn. This bettered the 773.84m consensus of the 4 analysts covering the company. This was 11.67% below the prior year's 2nd quarter results.
Average growth rate-2.20%
OCI N.V. had revenues for the full year 2023 of 5.02bn. This was 48.30% below the prior year's results.
Average growth rate+25.47%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.